Successful management of cesarean scar pregnancy progressive to placenta accreta spectrum: An uncommon condition in Vietnam and mini-review of the literature

剖宫产瘢痕妊娠进展为胎盘植入谱系疾病的成功管理:越南一种罕见疾病及文献简述

阅读:1

Abstract

INTRODUCTION AND IMPORTANCE: Cesarean scar pregnancy (CSP) is an uncommon ectopic pregnancy that could be progressive to the placenta accreta spectrum (PAS). It is defined as abnormal trophoblast invasion of part or all of the placenta into the myometrium of the uterine wall, with varying degrees of severity. These abnormal pathologies of placental implantation could lead to life-threatening complications for pregnant women. CASE PRESENTATION: A 39-year-old female patient was transferred to our consultant hospital for the diagnosis of CSP at 6 weeks of gestational age (GA). Due to asymptomatic presentation, the patient requested continuing pregnancy despite the high risk of uterine rupture and massive hemorrhage. The pregnant woman was strictly monitored on clinical aspects and ultrasound findings. Noticely, the PAS was suspected at 15-16 weeks of GA, and PAS type percreta was diagnosed at 22 weeks of GA. However, the woman continued her pregnancy and a planned cesarean delivery was performed at 34 weeks 6 days of GA. Additionally, modified one-step conservative surgery (MOSCUS) was successfully applied for uterine preservation. The materno-fetal outcomes were favorable. CLINICAL DISCUSSION: CSP is related to highly severe complications during pregnancy and the possibility of PAS. A timely termination of pregnancy ought to be discussed with the patient upon diagnosis. However, a proper management is more challenging for women desiring pregnancy. CONCLUSION: A continuing pregnancy and strict monitoring with a multidisciplinary team could be considered if the patient refuses medical abortion in cases of CSP progressive to PAS. Further data is needed on this entity.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。